In Memoriam
EVIDENCE THAT PRETRANSPLANT DONOR BLOOD TRANSFUSION PREVENTS RAT RENAL ALLOGRAFT DYSFUNCTION BUT NOT THE IN SITU CELLULAR ALLOIMMUNE OR MORPHOLOGIC MANIFESTATIONS OF REJECTION1 2
CYCLOSPORINE AND SKIN ALLOGRAFTS FOR THE TREATMENT OF THERMAL INJURY
CYCLOSPORINE AND SKIN ALLOGRAFTS FOR THE TREATMENT OF THERMAL INJURY
31P NUCLEAR MAGNETIC RESONANACE STUDY OF RENAL ALLOGRAFT REJECTION IN THE RAT
BONE MARROW TRANSPLATATION IN MINIATURE SWINE
BONE MARROW TRANSPLANTATION IN MINIATURE SWINE
CHANGE FROM AEROBIC TO ANAEROBIC METABOLISM AFTER BRAIN DEATH, AND REVERSAL FOLLOWING TRIIODOTHYRONINE THERAPY
SUCCESSFUL TRANSPLANTATIONO F 100 UNTRANSFUSED CYCLOSPORINE-TREATED PRIMARY RECIPIENTS OF CADAVERIC RENAL ALLOGRAFTS1 Presented in part at the 6th Annual Meeting of The American Socioety of Transplant Physicians, May 1987, Chicago, IL
KIDNEY RETRANSPLANTATION IN THE CYCLOSPORINE ERA1Pressented at the 6th Annual Meeting of the American Society of Transplant Physicians, May 1987, Chicago, IL
LONG-TERM RESULTS AND COMPLICATIONS IN RENAL TRANSPLANT RECIPIENTS
COMPLETE REPLACEMENT OF METHYLPREDNISOLONE BY AZATHIOPRINE IN CYCLOSPORINE-TREATED PRIMARY CADAVERIC RENAL TRANSPLANT RECIPIENTS1 Pressented at the 6th Annual Meeting of the American Society of Transplant Physicians, May 1987, Chicago, IL
COMPARISON OF INTRAVENOUS DIGITAL SUBTRACTION ANGIOGRAPHY AND CONVETIONAL ARTERIOGRAPHY IN DEFINING RENAL ANATOMY1 Pressented at the 6th Annual Meeting of the American Society of Transplant Physicians, May 1987, Chicago, IL
MICROALNUMINURIA AND HYPERTENSION IN LONG-TERM RENAL DONORS1 Pressented at the 6th Annual Meeting of the American Society of Transplant Physicians, May 1987, Chicago, IL
DELAYED RESPONSE TO ORTHOCLONE OKT-3 TREATMENTS FOR RENAL ALLOGRAFT REJECTION RESISTANT TO STEROID AND ANTILYMPHOCYTE GLOBULIN1 Pressented at the 6th Annual Meeting of the American Society of Transplant Physicians, May 1987, Chicago, IL
INCREASED INFECTIONS ASSOCIATED WITH THE USE OF OKT3 FOR TREATMENT OF STEROID-RESISTANT REJECTION IN RENAL TRANSPLANTATION1 Pressented at the 6th Annual Meeting of the American Society of Transplant Physicians, May 1987, Chicago, IL
IMPROVED IMMEDIATE FUNCTION OF RENAL ALLOGRAFTS WITH BELZER PERFUSATE1 Pressented at the 6th Annual Meeting of the American Society of Transplant Physicians, May 1987, Chicago, IL
INTERLEUKIN 2, INTERFERON, AND LYMPHOTOXIN IN RENAL TRANSPLANT RECIPIENTS1 Pressented at the 6th Annual Meeting of the American Society of Transplant Physicians, May 1987, Chicago, IL
BLOOD TRANSFUSIONS AND HLA MATCHING—AN EITHER/OR SITUATION IN CADAVERIC RENAL TRANSPLANTATION1 Pressented at the 6th Annual Meeting of the American Society of Transplant Physicians, May 1987, Chicago, IL
SERUM CYCLOSPORINE KINETIC PROFILE
ASSOCIATIONS BETWEEN CYCLOSPORINE THERAPY AND INTERSTITIAL FIBROSIS IN RENAL ALLOGRAFT BIOPSIES1,2
EVALUATION OF ANTIBODY SYNTHESIS IN BROADLY SENSITIZED PATIENTS1
PREDICTION OF DONOR-SPECIFIC TRANSFUSION SENSITIZATON
THE USE OF SINGLE PEDIATRIC CADAVER KIDNEYS FOR TRANSPLANTATION1
INCIDENCE AND MORBIDITY OF CYTOMEGALOVIRUS DISEASE ASSOCIATED WITH A SERONEGATIVE RECIPIENT RECEIVING SEROPOSITIVE DONOR-SPECIFIC TRANSFUSION AND LIVING-RELATED DONOR TRANSPLANTATION
THE IMPACT OF CYTOMEGALOVIRUS INFECTION ON SERONEGATIVE RECIPIENTS OF SEROPOSITIVE DONOR KIDNEYS VERSUS SEROPOSITIVE RECIPIENTS TREATED WITH CYCLOSPORINE-PREDNISONE IMMUNOSUPPRESSION
FACTORS INFLUENCING EARLY RENAL FUNCTION IN CADAVER KIDNEY TRANSPLANTS
IMPROVED RENAL ALLOGRAFT SURVIVAL FOLLOWING DONOR-SPECIFIC TRANSFUSIONS
ENUMERATION OF LEU2a±us;, LEU2a+-DR+, AND LEU2a+-LEU15+ CELLS IN PERIPHERAL BLOOD OF RENAL TRANSPLANT PATIENTS
ADENINE NUCLEOTIDE METABOLISM AND ITS RELATION TO ORGAN VIABILITY IN HUMAN LIVER TRANSPLANTATION1
SERUM IMMUNOREACTIVE INTERLEUKIN 1 IN RENAL TRANSPLANT RECIPIENTS
DETERMINATION OF WARMS ISCHEMIA TIME AT DONOR NEPHRECTOMY1
SELECTIVE ENHANCEMENT OF THROMBOXANE IN MACROPHAGES AND KIDNEYS IN CYCLOSPORINE-INDUCED NEPHROTOXICITY
THE IN VIVO IMMUNOSUPPRESSIVE ACTION OF SUPPRESSOR CELLS FROM ALLOANTIGEN-CYCLOSPORINE-TREATED MICE AND THE CAPACITY OF SPLEEN CELLS TO RELEASE INTERLEUKINS AND -INTERFERON1
SYNERGY BETWEEN SUBTHERAPEUTIC DOSES OF CYCLOSPORINE AND IMMUNOLOGIC ENHANCEMENT IN RAT RECIPIENTS OF CARDIAC ALLOGRAFTS1
CELLULAR PATHWAYS FOR REJECTION OF CLASS-I-MHCDISPARATE SKIN AND TUMOR ALLOGRAFTS1
LOSS OF F1 HYBRID RESISTANCE TO BONE MARROW GRAFTS AFTER INJECTION OF PARENTAL LYMPHOCYTES
NEPHROTOXICITY OF CYCLOSPORINE A AND CYCLOSPORINE G IN A RAT MODEL1
INHIBITOIN OF ANTIGEN-SPECIFIC ACTIVATION OF AN L3T4+ T CELL LINE BY CYCLOSPORINE WITH MAINTENANCE OF MACROPHAGE-MEDIATED ANTIGEN PRESENTATION1
BLOCKING OF T CELL ACTIVATION AT THE G1A/G1B INTERFACE OF THE CELL CYCLE AND PREVENTION OF EXPRESSION OF INTERLEUKIN 2 RECEPTORS BY ALLOACTIVATED SUPPRESSOR T LYMPHOCYTES
FACTORS AFFECTING THE ACCEPTANCE OF DEOXYGUANOSINE-TREATED THYMUS ALLOGRAFTS1
PROLONGATION OF SKIN ALLOGRAFT SURVIVAL IN RATS BY A NOVEL IMMUNOSUPPRESSIVE AGENT, FK 506
TRANSFER OF CYCLOSPORINE-ASSOCIATED SYNGENEIC GRAFT-VERSUS-HOST DISEASE BY THYMOCYTES
DOMINATION BY EPIDERMAL CELL-REACTIVE AUTOANTIBODIES IN ATTEMPTS TO RAISE ANTIBODIES TO Epa-1 ALLOANTIGENS1
Transplantation
DONOR-SPECIFIC TRANSFUSIONS BEFORE TRANSPLANTATION A Comparison of Results in Children and Adults at the Same Insttution1
DELAYED ALLOGRAFT REJECTION IN PRIMATES TREATED WITH ANTI-IL-2 RECEPTOR MONOCLONAL ANTIBODY CAMPATH-6
PRODUCTION OF INDEFINITE RENAL ALLOGRAFT SURVIVAL IN THE RAT BY PRETREATMENT WITH VIABLE AND NONVIABLE HEPATOCYTES OR LIVER MEMBRANE EXTRACTS1
TREATMENT OF CHRONIC RENAL ALLOGRAFT REJECTION WITH CYCLOSPORINE AND PREDNISONE
EFFECT OF LOW-TEMPERATURE CULTURE ON THE SURVIVAL OF INTRATESTICULAR RAT ISLET ALLOGRAFTS1
FAILURE OF ANTITHYMOCYTE SERUM POSTGRAFTING TO OVERCOME “RESISTANCE” TO DLANONIDENTICAL CANINE MARROW GRAFTS1
CONTROL OF pH DURING HYPOTHERMIC LIVER STORAGE
GRAFT STABILITY IN A HEART TRANSPLANT RECIPIENT WHOSE IMMUNOSUPPRESSIVE THERAPY WAS DISCONTINUED FOR 8 MONTHS1
ADDITONAL TOTAL-LYMPHOID IRRADIATION IN PREVENTING GRAFT FAILURE OF T-CELL-DEPLETED BONE MARROW TRANSPLANTATION FROM HLA-IDENTICAL SIBLINGS
RECURRENT HEMOLYTIC UREMIC SYNDROME IN A RENAL TRANSPLANT RECIPIENT AND REVIEW OF THE LEIDEN EXPERIENCE
FAILURE TO DECREASE ANTIBODY LEVELS IN SENSITIZED PATIENTS BY REPEATED TRANSFUSIONS FROM ONE DONOR AND CYCLOSPORINE
GRAFT-VERSUS-HOST-LIKE DISEASE IN A HEART ALLOGRAFT RECIPIENT
Transplantation